Objectives: This study aimed to determine the prevalence of urinary schistosomiasis, and the effect of CD4(+) T cell counts and demographics on its prevalence among HIV-positive patients in Benin City, Nigeria.

Methods: Urine and blood samples were collected from 2000 HIV-positive subjects. A wet preparation of the urine deposit was examined microscopically to identify ova of Schistosoma haematobium. The blood specimens were analyzed using the flow cytometry for CD4 (+) T-lymphocyte count.

Results: An overall prevalence rate of 0.3% was reported. Gender and CD4 count <200 cells/µL did not affect the prevalence of urinary schistosomiasis, while HIV patients that were single had significantly higher prevalence of urinary schistosomiasis (p=0.002).

Conclusion: The prevalence of urinary schistosomiasis among HIV patients in Benin City is low. CD4(+) count did not affect the prevalence of urinary schistosomiasis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3191685PMC
http://dx.doi.org/10.5001/omj.2011.42DOI Listing

Publication Analysis

Top Keywords

urinary schistosomiasis
8
benin city
8
proportion urinary
4
schistosomiasis hiv-infected
4
hiv-infected subjects
4
subjects benin
4
city nigeria
4
nigeria objectives
4
objectives study
4
study aimed
4

Similar Publications

Background: Adequate knowledge and awareness regarding diseases are essential for appropriate, high-quality healthcare. Female Genital Schistosomiasis (FGS) is a non-sexually transmitted gynaecological disease that is caused by the presence of Schistosoma haematobium eggs in the female genital tract and the resulting immune response that causes tissue damage. It is estimated to affect 56 million women, mostly in sub-Saharan Africa (SSA), where healthcare workers (HCWs) have limited awareness and knowledge of FGS.

View Article and Find Full Text PDF

Development and Application of an In Vitro Drug Screening Assay for Schistosomula Using YOLOv5.

Biomedicines

December 2024

Infectious and Tropical Diseases Research Group (e-INTRO), Biomedical Research Institute of Salamanca, Research Centre for Tropical Diseases at the University of Salamanca (IBSAL-CIETUS), Faculty of Pharmacy, University of Salamanca, 37007 Salamanca, Spain.

Background: Schistosomiasis impacts over 230 million people globally, with 251.4 million needing treatment. The disease causes intestinal and urinary symptoms, such as hepatic fibrosis, hepatomegaly, splenomegaly, and bladder calcifications.

View Article and Find Full Text PDF

Background: S. haematobium is a recognized carcinogen and is associated with squamous cell carcinoma of the bladder. Its association with high-risk(HR) human papillomavirus (HPV) persistence, cervical pre-cancer and cervical cancer incidence has not been fully explored.

View Article and Find Full Text PDF

Schistosomiasis is a tropical infection endemic to developing nations that can result in chronic liver damage, renal failure, infertility, and bladder cancer. Genitourinary localization is marked by dysuria, visible hematuria, and urinary obstruction. We present the case of a 17-year-old male adolescent from a rural area of Central Africa, who arrived in Italy two years prior, exhibiting hematuria and urinary symptoms.

View Article and Find Full Text PDF

A Retrospective Study of Urinary Schistosomiasis in the Eastern Cape Province, South Africa.

Trop Med Infect Dis

November 2024

HERENDA Program, New Medical School, Walter Sisulu University, Nelson Mandela Drive, Mthatha 5100, Eastern Cape, South Africa.

Schistosomiasis is caused by infection with trematode flukes of the genus Schistosoma. More than 700 million people worldwide are estimated to be susceptible to infection. In sub-Saharan Africa, schistosomiasis is the second most widespread neglected tropical disease after malaria.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!